Mallia Therapeutics | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
Mallia Therapeutics

BRIEF

published on 05/21/2025 at 10:05, 6 months 14 days ago

Mallia Therapeutics Presents New Alopecia Treatment at EHRS

Alopecia Treatment SCD83 Therapy Hair Growth Innovation EHRS Conference Topical Application
BRIEF

published on 05/21/2025 at 10:05, 6 months 14 days ago

Mallia Therapeutics présente un nouveau traitement contre l'alopécie à l'EHRS

Traitement De L'alopécie Thérapie SCD83 Innovation En Matière De Croissance Des Cheveux Conférence EHRS Application Topique
PRESS RELEASE

published on 05/21/2025 at 10:00, 6 months 14 days ago

Mallia Therapeutics reports on novel therapeutic approach for treating alopecia at the annual meeting of the European Hair Research Society (EHRS)
Mallia Therapeutics presents innovative sCD83-based approach for alopecia treatment at EHRS 2025 annual meeting, aiming to revolutionize hair loss therapy

Hair Loss EHRs Mallia Therapeutics SCD83 Alopecia
BRIEF

published on 02/04/2025 at 10:05, 10 months ago

Mallia Therapeutics and Northway Biotech Partner for Hair Loss Treatment Production

Partnership Hair Loss Treatment Biologics Manufacturing SCD83 Protein Alopecia Market
BRIEF

published on 02/04/2025 at 10:05, 10 months ago

Mallia Therapeutics et Northway Biotech s'associent pour la production de traitements contre la perte de cheveux

Partenariat Fabrication De Produits Biologiques Traitement De La Perte De Cheveux Protéine SCD83 Marché De L'alopécie
PRESS RELEASE

published on 02/04/2025 at 10:00, 10 months ago

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
Mallia Therapeutics and Northway Biotech partner to manufacture soluble CD83 protein for hair loss treatment. The collaboration aims to develop a scalable production process and explore new treatment approaches

Manufacturing Hair Loss Treatment Mallia Therapeutics Northway Biotech CD83 Protein
PRESS RELEASE

published on 07/11/2023 at 09:30, 2 years 4 months ago

Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 55 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 30 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 25 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 30 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 29 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 59 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 39 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 4 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 14 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 15 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 30 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 30 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 45 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 45 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE